Public interest groups, known for advocating for human rights and civil liberties, are now playing an increasingly important role in the world of intellectual property law.
This was clearly demonstrated last week when the American Civil Liberties Union, together with the Public Patent Foundation, asked the U.S. Supreme Court to invalidate patents held by Myriad Genetics Inc. on two genes associated with hereditary breast and ovarian cancers. A week earlier, the Electronic Frontier Foundation joined up with the Samuelson Law, Technology and Public Policy Clinic at Berkeley Law School, urging the U.S. Patent and Trademark Office to conduct a reexamination of a patent for a system that tracks vehicles’ locations.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
